Enterprise Ireland congratulates client company Neuravi, an Irish medical technology company which develops innovative devices for stroke therapy, on the announcement today that it has been acquired by Johnson & Johnson.
The company’s innovative EmboTrap Revascularization Platform device captures and removes clots from blood vessels and restores bloodflow and helps reduce the long-term effects of stroke.
Enterprise Ireland, the state agency responsible for the development of innovative Irish companies was an early investor in the company and has worked closely with Galway based Neuravi to invest in and support their ongoing research and innovation activity.
It is anticipated that the operations will continue and expand from its Galway base. Neuravi will continue to play an important role in the development of the Irish medtech innovation ecosystem which employs approximately 40,000 people in Ireland.